About epinephrine autoinjector
Epinephrine is among the first line of treatment drugs for anaphylactic conditions and is considered a life-saving drug during emergencies. Epinephrine autoinjectors have proved to be a life savior for people with severe allergies from as early as the 1980s. The global epinephrine autoinjector market has been witnessing continuous technological innovations and developments over the years, after the first FDA approval of EpiPen in 1987.
Technavio’s analysts forecast the global epinephrine autoinjector market to grow at a CAGR of 14.58% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global epinephrine autoinjector market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various epinephrine autoinjectors to key end-users such as hospitals, clinics, and individuals.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Epinephrine Autoinjector Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• ALK-Abelló
• Impax Laboratories
• Lincoln Medical
• Mylan
Other prominent vendors
• Adamis Pharmaceuticals
• Antares Pharma
• Emerade
• Hospira
• Kaleo Pharma
• Teva Pharmaceutical Industries
Market driver
• Increasing prevalence of allergies
• For a full, detailed list, view our report
Market challenge
• Product recalls and regulatory issues
• For a full, detailed list, view our report
Market trend
• Tentative product launches
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Epinephrine autoinjector: Overview
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by dosage
• Global epinephrine autoinjector market by 0.15gm dosage
• Global epinephrine autoinjector market by 0.30gm dosage
• Global epinephrine autoinjector market by 0.5gm dosage
PART 07: Market segmentation by age group
PART 08: Market segmentation by end-user
• Hospitals and clinics
• Individuals
PART 09: Geographical segmentation
• Epinephrine autoinjector market in the Americas
• Epinephrine autoinjector market in EMEA
• Epinephrine autoinjector market in APAC
PART 10: Market drivers
• Increasing prevalence of allergies
• Technological advances
• Marketing strategies
PART 11: Impact of drivers
PART 12: Market challenges
• Product recalls and regulatory issues
• Presence of substitutes
• High cost
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Tentative product launches
• Growing awareness about epinephrine autoinjectors
• Patient assistance programs
PART 15: Vendor landscape
• Competitive scenario
• Key news
• Geographical presence of key vendors
PART 16: Key vendor analysis
• ALK-Abelló
• Impax Laboratories
• Lincoln Medical
• Mylan
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global epinephrine autoinjector market: Analysis
Exhibit 03: Key buying criteria for epinephrine autoinjectors
Exhibit 04: Buying criteria for epinephrine autoinjectors
Exhibit 05: Key factors influencing development of epinephrine autoinjectors
Exhibit 06: Allergy statistics
Exhibit 07: Market overview: Global epinephrine autoinjector market
Exhibit 08: Global epinephrine autoinjector market ($ millions)
Exhibit 09: Global epinephrine autoinjector market analysis: Developed and developing markets
Exhibit 10: Five forces analysis
Exhibit 11: Global epinephrine autoinjector market segmentation by dosage 2016
Exhibit 12: Global epinephrine autoinjector market segmentation by dosage 2020
Exhibit 13: Global epinephrine autoinjector market by 0.15gm dosage 2016-2021 ($ millions)
Exhibit 14: Global epinephrine autoinjector market by 0.30gm dosage 2016-2021 ($ millions)
Exhibit 15: Global epinephrine autoinjector market by 0.5gm dosage 2016-2021 ($ millions)
Exhibit 16: Global epinephrine autoinjector market segmentation by dosage 2016-2021 (%)
Exhibit 17: Global epinephrine autoinjector market segmentation by dosage 2016-2021 ($ millions)
Exhibit 18: Global epinephrine autoinjector market by age group 2016
Exhibit 19: Global epinephrine autoinjector market by end-user 2016
Exhibit 20: Global epinephrine autoinjector market segmentation by geography 2016
Exhibit 21: Global epinephrine autoinjector market segmentation by geography 2021
Exhibit 22: Epinephrine autoinjector market in the Americas 2016-2021 ($ millions)
Exhibit 23: Market overview: Americas
Exhibit 24: Epinephrine autoinjector market overview: US
Exhibit 25: Epinephrine autoinjector market in the US 2016-2021 ($ millions)
Exhibit 26: Market overview: EMEA
Exhibit 27: Epinephrine autoinjector market in EMEA 2016-2021 ($ millions)
Exhibit 28: Market overview: APAC
Exhibit 29: Epinephrine autoinjector market in APAC 2016-2021 ($ millions)
Exhibit 30: Global epinephrine autoinjector market segmentation by geography 2016-2021 ($ millions)
Exhibit 31: Global epinephrine autoinjector market segmentation by geography 2016-2021 (%)
Exhibit 32: Allergy statistics
Exhibit 33: Technological advances
Exhibit 34: Marketing strategies of Mylan
Exhibit 35: Impact of drivers
Exhibit 36: Product recalls
Exhibit 37: Alternatives of epinephrine autoinjectors in the market
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Competitive structure of the global epinephrine autoinjector market
Exhibit 40: Market penetration of various epinephrine autoinjector manufacturers globally (2016)
Exhibit 41: Strategic success factors of companies in global epinephrine autoinjector market 2016
Exhibit 42: Share of vendors in global epinephrine autoinjector market 2016
Exhibit 43: Regional analysis of key vendors
Exhibit 44: Key highlights of ALK-Abelló
Exhibit 45: ALK-Abelló strength assessment
Exhibit 46: ALK-Abelló strategy assessment
Exhibit 47: ALK-Abelló opportunity assessment
Exhibit 48: Key highlights of Impax Laboratories
Exhibit 49: Impax Laboratories strength assessment
Exhibit 50: Impax Laboratories strategy assessment
Exhibit 51: Impax Laboratories opportunity assessment
Exhibit 52: Lincoln Medical strength assessment
Exhibit 53: Lincoln Medical strategy assessment
Exhibit 54: Lincoln Medical opportunity assessment
Exhibit 55: Key highlights of Mylan
Exhibit 56: Mylan strength assessment
Exhibit 57: Mylan strategy assessment
Exhibit 58: Mylan opportunity assessment
